Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

Novel Biomarkers In Heart Failure At Heart Failure Congress 2009
Several new biomarkers have been recently described in Heart Failure (HF) syndrome either in stable chronic patients as in the settings of acute decompensation. Biomarkers are used to diagnose disease risk, to predict outcome and to tailor treatment to individuals.
generic viagra
In Mouse Study Immune Cells Ameliorate Hypertension-Induced Cardiac Damage
Researchers in Berlin, Germany have found that a specific type of immune cell, the regulatory T lymphocyte (Treg) plays an important role in hypertension-induced cardiac damage. The injected Treg that they harvested from donor mice into recipient mice were infused with angiotensin II, a blood pressure-raising peptide. The Tregs had no influence on the blood pressure response to angiotensin II. Nonetheless, cardiac enlargement, fibrosis, and inflammation was sharply reduced by Treg treatment. Furthermore, the tendency to develop abnormal heart rhythms that could lead to sudden cardiac death was also reduced. Dr. Heda Kvakan and Dr. Dominik N. MÃøller at the Experimental and Clinical Research Center at the Max DelbrÃøck Center do not intend Treg as a therapy. However, a better understanding of how the immune system fits into hypertension-induced organ damage could result from these studies (Circulation, Vol. 119, No. 22, June 9, 2009, 2904-2912 ).*
Zubni implantati
News of the day
Study Shows Risks Of Delaying ACL Reconstruction In Young Athletes
More and more children are participating and getting hurt playing sports each year. A new study presented at the American Orthopaedic Society for Sports Medicine"s (AOSSM) Annual Meeting in Keystone, Colorado, (July 9-12) details the benefits and risks of repairing a torn anterior cruciate ligament (ACL) in young athletes under the age of 14.
Endocrinology

The Union Opens DR Congo Country Office

The Union is opening an office in Kinshasa to support its TB, TB-HIV and other collaborations with the National Tuberculosis Programme, Ministry of Health and other partners. After several years of working in the Democratic Republic of Congo, The Union decided, in consultation with the National Tuberculosis Programme (NTP), that it was time to open a representative office in Kinshasa. The Union"s goal is to strengthen its partnership with the NTP and the Ministry of Health by building a greater day-to-day knowledge of the issues they are facing regarding tuberculosis, respiratory health and AIDS. This initiative will also help The Union and its partners to document lessons learned in the field and understand how to adapt international strategies to the Congolese context. The Union and the NTP are working together on the IHC programme (Integrated HIV Care for Tuberculosis Patients Living with HIV / AIDS), which has been funded by the European Commission and takes place in North Kivu. The partners are implementing a research project on the operational feasibility of managing HIV-TB co-infection using the health staff at basic health facilities that offer a screening service and treatment of tuberculosis and AIDS. The Union, La Ligue Nationale Anti-Tuberculeuse and the NTP are also collaborating as part of the TB CAP (TB Control Assistance Program), which is funded by the United States Agency for International Development (USAID). Finally, The Union supports the NTP in other areas, including management of its health information and exchange experiences with other African countries with funding from the Agence FranÃýaise de Développement . It also supports the participation of NTP representatives in international training and funds their participation in world conferences on tuberculosis, where they are regularly asked to present the results of the DRC"s programme. WHO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009